SCHEMBL699230

SCHEMBL699230

COc1ccc(C(=O)O)c(C(=O)c2ccccc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.71
HTT P42858 2/20 0.71
MAPK1 P28482 2/20 0.71
LMNA P02545 2/20 0.71
HPGD P15428 2/20 0.71
CYP1A2 P05177 1/20 0.71
PGR P06401 1/20 0.71
CYP2D6 P10635 1/20 0.71
SLC6A2 P23975 1/20 0.71
PDE4A P27815 1/20 0.71
CYP2C19 P33261 1/20 0.71
HRH1 P35367 1/20 0.71
SLC6A3 Q01959 1/20 0.71
PDE4D Q08499 1/20 0.71
POLB P06746 4/20 0.62
KDM4E B2RXH2 4/20 0.62
MAPT P10636 3/20 0.58
NPSR1 Q6W5P4 1/20 0.58
RAB9A P51151 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3480945 0.93 ALDH1A1 (0.71) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL7822107 0.90 CYP2C8 (0.64) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL27618688 0.87 ALDH1A1 (0.63) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL17080310 0.86 ALDH1A1 (0.66) ALDH1A1HTTMAPK1LMNAHPGD
Benzene SCHEMBL29227606 0.86 ALDH1A1 (0.63) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL3624583 0.85 NPC1 (0.55) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL27939607 0.85 CDC25B (0.66) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL4124832 0.85 NPC1 (0.68) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL4833882 0.84 CDC25B (0.61) ALDH1A1HTTMAPK1LMNAHPGD
SCHEMBL4842051 0.84 CYP2C8 (0.64) ALDH1A1HTTMAPK1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
EP-3356356-B1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-05-26 EP disclosed
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US disclosed
US-20190177308-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. 2019-06-13 US disclosed
US-20180273517-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX INC (US) 2018-09-27 US disclosed
EP-3356356-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2018-08-08 EP disclosed
US-9732071-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-08-15 US disclosed
US-20170143022-A1 Compositions Incorporating an Umami Flavor Agent SENOMYX INC (US) 2017-05-25 US disclosed
US-20170096418-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-04-06 US disclosed
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION SENOMYX INC (US) 2017-03-30 US disclosed
WO-2007121600-A1 NUCLEIC ACID, POLYPEPTIDE AND ITS USE GIVAUDAN SA (CH) 2007-11-01 WO disclosed
US-20070054892-A1 Isoquinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. 2007-03-08 US disclosed
US-20070054892-A1 Isoquinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. 2007-03-08 US disclosed
US-20060275765-A1 G-proteins GIVAUDAN SA (CH) 2006-12-07 US disclosed
EP-1581555-A2 G-PROTEINS Givaudan SA (CH) 2005-10-05 EP disclosed
WO-2004055048-A2 CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS GIVAUDAN SA (CH) 2004-07-01 WO disclosed
EP-0575425-B1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1995-10-11 EP disclosed
EP-0575425-A1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES. BOEHRINGER MANNHEIM GMBH (DE) 1993-12-29 EP disclosed
WO-1992016207-A1 USE OF OXAZOLO-[2,3-a]ISOINDOLE AND IMIDAZO[2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO[2,3-a]ISOINDOLE DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1992-10-01 WO disclosed
US-4505921-A Sulfonylurea compounds and their use in treating diabetes ADIR, S.A.R.L. (FR) 1985-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 ALDH1A1 3726/4885HTT 3860/4885MAPK1 1501/4885
US-20170143022-A1 Compositions Incorporating an Umami Flavor Agent TAS2R8, TAS2R45, TAS2R40 ALDH1A1 263/4885HTT 1966/4885MAPK1 2740/4885
US-20190177308-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM6, TRPM4 ALDH1A1 3880/4885HTT 4111/4885MAPK1 1875/4885
US-20180273517-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM6, TRPM4 ALDH1A1 3880/4885HTT 4111/4885MAPK1 1875/4885
US-20170087199-A1 COMPOSITIONS FOR DELIVERING A COOLING SENSATION TRPA1, PDE6G, PDE6D ALDH1A1 1029/4885HTT 191/4885MAPK1 864/4885
US-20170096418-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM6, TRPM4 ALDH1A1 3880/4885HTT 4111/4885MAPK1 1875/4885
US-20070054892-A1 Isoquinoline potassium channel inhibitors KCNQ1, KCNQ2, KCNQ5 ALDH1A1 1553/4885HTT 3339/4885MAPK1 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.